Delivery Order SPE2DB24D2205-SPE2DB25FDZWT
Award Date
3/20/25
Potential Completion Date
3/21/25
Potential Value
$4.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,308.08 Firm Fixed Price Delivery Order contract is for the supply of 4567331014 - MYCOPHENOLATE 500 MG TABLET 500S, with a completion date of February 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,364.70 firm fixed-price delivery order is for Mycophenolate 500 mg tablets, a specialty medication. The contract has a ceiling value of $1,364.70 and an ultimate completion date of February 12, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,717.88 firm fixed-price delivery order is for the supply of 4,563,279,114 units of mycophenolic acid delayed-release 360 mg tablets in 120-count packages. The contract has a period of performance through January 10, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of mycophenolate 500 mg tablets. The contract has a ceiling value of $1,832.60 and a period of performance through August 5, 2024. The contract is a delivery order and utilizes a firm fixed-price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Mycophenolate 500 mg vials. The $1,563.15 firm fixed-price delivery order has a completion date of December 20, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Mycophenolate 500 mg tablets. The $2,563.60 Firm Fixed Price contract has a completion date of November 28, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,743.88, is for the delivery of MYCOPHENOLATE 500 MG TABLET 500S, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, a firm fixed price delivery order, is for the supply of Mycophenolate 500 mg tablets. The contract has a ceiling value of $2,073.55 and a period of performance through April 3, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an...
This federal contract award, valued at $4,034.81, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of MYCOPHENOLATE 500 MG TABLET 500S, a pharmaceutical product, with a period of performance through July 10, 2024. This contract is not designated as a set-aside award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract worth $3,066.66 by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of MYCOPHENOLATE 500 MG TABLET 500S, a pharmaceutical product, with a completion date of January 26, 2024. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through...